Biontech SE
BNTX
View Detailed Chart
88.770USD
+1.960+2.26%
Close 03/25, 16:00（ET）Quotes delayed by 15 min
22.31BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.26%
5 Days
-1.37%
1 Month
-19.18%
6 Months
-9.49%
Year to Date
-6.75%
1 Year
-8.53%
View Detailed Chart
TradingKey Stock Score of Biontech SE
Currency: USD Updated: 2026-03-24Key Insights
Biontech SE's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 130.06.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Biontech SE's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Biontech SE Highlights
StrengthsRisks
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Fairly Valued
The company’s latest PE is -21.69, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 54.72M shares, decreasing 0.02% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 188.70K shares of this stock.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
130.062
Target Price
+45.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Biontech SE News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Biontech SE Info
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Ticker SymbolBNTX
CompanyBiontech SE
CEOSahin (Ugur)
Websitehttps://www.biontech.com/
Related Instruments
+1.47%
+0.11%
+1.98%
+0.73%
+2.58%
+0.96%
+1.44%
+1.58%
-0.25%
+1.19%
-1.52%
+3.31%
+1.97%
+2.70%
+1.42%
0.00%
+1.97%
+1.05%
+0.67%
+1.39%Popular Symbols
252.620
+0.980 (+0.39%)
178.680
+3.480 (+1.99%)
71292.910
+313.410 (+0.44%)
296.140
-4.910 (-1.63%)
2165.500
+1.510 (+0.07%)
385.950
+2.920 (+0.76%)
4532.320
+26.880 (+0.60%)
90.972
+0.033 (+0.04%)
1.157
+0.001 (+0.06%)
159.436
-0.023 (-0.01%)
